SCHEMBL21929261

SCHEMBL21929261

N#Cc1ccc(-c2cc(-n3c4cc(C#N)ccc4c4ccc(C#N)cc43)ncc2-n2c3cc(C#N)ccc3c3ccc(C#N)cc32)cc1

nearest known ligand 0.37

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP11B2 P19099 6/20 0.37
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
PTGER4 P35408 1/20 0.34
CYP11B1 P15538 1/20 0.34
PGR P06401 2/20 0.33
MAP4K4 O95819 2/20 0.33
SLC22A12 Q96S37 1/20 0.33
EGLN1 Q9GZT9 2/20 0.33
USP14 P54578 1/20 0.33
PLAU P00749 1/20 0.33
NR3C1 P04150 1/20 0.32
NR3C2 P08235 1/20 0.32
AR P10275 1/20 0.32
CDC7 O00311 1/20 0.32
RIPK1 Q13546 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21931729 0.94 PTGER4 (0.41) CYP11B2KDM4EALDH1A1L3MBTL1PTGER4
SCHEMBL21929230 0.94 CHEK1 (0.37) CYP11B2KDM4EALDH1A1L3MBTL1PTGER4
SCHEMBL21928600 0.91 GRM5 (0.39) ALDH1A1MAP4K4PLAU
SCHEMBL23098053 0.90 GRM2 (0.41) CYP11B2KDM4EALDH1A1L3MBTL1PTGER4
SCHEMBL21929048 0.90 CYP11B2 (0.34) CYP11B2KDM4EALDH1A1L3MBTL1PTGER4
SCHEMBL21929027 0.90 STS (0.38) CYP11B2KDM4EALDH1A1L3MBTL1PTGER4
SCHEMBL21929262 0.90 CYP11B2 (0.37) CYP11B2KDM4EALDH1A1L3MBTL1PTGER4
SCHEMBL21931728 0.89 GABRA1 (0.40) CYP11B2ALDH1A1PTGER4MAP4K4EGLN1
SCHEMBL21928981 0.89 CLK4 (0.40) MAP4K4PLAU
SCHEMBL21931745 0.88 CLK4 (0.41) CYP11B2KDM4EALDH1A1L3MBTL1PTGER4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220388960-A1 ORGANIC MOLECULES FOR USE IN LIGHT-EMITTING DEVICES CYNORA GMBH (DE) 2022-12-08 US disclosed
EP-3609978-B1 ORGANIC MOLECULES IN PARTICULAR FOR USE IN OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2021-03-17 EP disclosed
US-20200136054-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2020-04-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200136054-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES OR10J3, OGFR, OR51E2 CYP11B2 902/4885KDM4E 1828/4885ALDH1A1 1092/4885
US-20220388960-A1 ORGANIC MOLECULES FOR USE IN LIGHT-EMITTING DEVICES ALDH1A2, AOX1, CYBA CYP11B2 163/4885KDM4E 4010/4885ALDH1A1 6/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.